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In order to test the hypothesis that gut hormones may be involved in mediating the symptoms of the acute attack of AlP, we took blood samples four-hourly during the first 24-48 hours after admission in two patients in two AlP attacks. Levels of gastrin, insulin, pancreatic . polypeptide (PP), somatostatin and vasoactive intestinal peptide were found to be normal, although insulin and PP levels increased to four times basal levels at times when the patients complained of increased abdominal pain. It is, however, impossible to ascertain whether these increases are related to the cause of the exacerbation or simply reflect a response to stress. Perhaps measurement of substance P or neurotensin might yield more interesting results.
The results of treatment with glucagon are highly preliminary. No severe attacks were treated, but the idea remains attractive especially if the glucagon can be given early in the attack while glycogen stores in the liver may still be plentiful. If other workers can show that glucagon, by causing glycogenolysis within the hepatocyte, reduces ALA-S activity -even if in only a proportion of acute attacks -then a case could be made for supplying sufferers with the drug to administer to themselves by subcutaneous or intramuscular injection as early as possible in the acute attack in order to abort it. RICHARD It is reasonable to conclude that the temporal lobes, together and singly, are involved in a large number of higher cognitive functions. Before these can be well understood, their clinical correlates will have to be precisely diagnosed and classified. Substance P is a small peptide (I I amino acids) discovered by von Euler and thought to be the neurotransmitter in primary sensory nerves (Lembeck 1953) . It is present in large quantities in the gut and central nervous system. Animal experiments have shown it to be a powerful vasodilator agent and it induces hypotension in various species when injected intravenously (Dobbins et al. 1982 , von Euler 1981 . We report here the effects of an accidental injection of substance P into a human subject.
The victim of the accident was a female student aged 23, weighing 45 kg. Whilst performing an
